Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

429
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
429
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
116

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The "Hit-and-Run" legacy: epigenetic locking and the survival switch in H. pylori-associated gastric cancer.

Cell death discovery·2026
Same author

Beyond non-anatomical resections: Is minimally invasive parenchyma-sparing anatomical hepatectomy the next chapter?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Learning Curves and Complexity Evolution in Robotic Liver Surgery: An International Multicenter Study with Comparison to Global Benchmark Outcomes.

Annals of surgery·2026
Same author

Risk factors for posthepatectomy liver failure: a secondary analysis of prospective clinical trials.

Langenbeck's archives of surgery·2026
Same author

Semi-automated isolation of parenchymal and non-parenchymal liver cells from mice and humans with enhanced stellate cell fraction.

Cell & bioscience·2026
Same author

ASO Author Reflections: It Takes Two to SAMBA-Toward Standardized Robotic Parenchymal Transection with Sealing Devices.

Annals of surgical oncology·2026

相关实验视频

Updated: Jun 3, 2025

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
11:03

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst

Published on: June 24, 2022

5.5K

[肝脏手术中的多发性疾病]

Emrullah Birgin1, Jan Heil2, Elisabeth Miller2

  • 1Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland. emrullah.birgin@uniklinik-ulm.de.

Chirurgie (Heidelberg, Germany)
|January 8, 2025
PubMed
概括
此摘要是机器生成的。

多病症患者在切除肝脏后面临更高的风险,特别是在开放式手术和某些肝脏疾病中. 最少侵入性手术和增强的恢复协议可以显著改善结果.

关键词:
慢性疾病 慢性疾病脆弱性 脆弱性 脆弱性切除肝脏切除 切除肝脏切除结果结果的结果.萨尔科佩尼亚是什么意思 萨尔科佩尼亚

更多相关视频

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.4K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

511

相关实验视频

Last Updated: Jun 3, 2025

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
11:03

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst

Published on: June 24, 2022

5.5K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.4K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

511

科学领域:

  • 肝胆道手术是肝胆道的手术.
  • 老年医学 老年医学
  • 慢性疾病管理 慢性疾病管理

背景情况:

  • 多种疾病,定义为≥3种慢性疾病,影响超过50%的患者>60岁.
  • 查尔森并发症指数 (CCI) 量化了多病症的严重程度及其对手术结果的影响.
  • 多病症患者在肝切除后患病和死亡风险增加,主要是由于肝衰竭.

研究的目的:

  • 分析多病症对肝切除结果的影响.
  • 确定肝脏手术的多病患者的特定风险因素和保护策略.

主要方法:

  • 关于多病症,查尔森并发症指数和肝切除结果的文献综述.
  • 风险因素分析,包括手术方法 (开放式或微创手术) 和特定疾病,如代谢相关脂肪肝疾病 (MAFLD).

主要成果:

  • 开放性主要肝切除,特别是在胆道重建和在患有MAFLD相关的肝脏原发性瘤的患者中,显著增加了术后风险.
  • 最少侵入性肝切除表明术后发病率和死亡率显著降低.
  • 肝脏预条件和手术后增强恢复 (ERAS) 协议对术后结果产生积极影响.

结论:

  • 多病症在肝切除方面带来了重大挑战,增加了并发症和死亡风险.
  • 最少侵入性技术和遵守ERAS原则对于改善多病患者手术结果至关重要.
  • 量身定制的术后策略对于管理接受肝脏手术的高风险多病症患者至关重要.